Literature DB >> 22046196

Clinical aspects of Marburg hemorrhagic fever.

Masfique Mehedi1, Allison Groseth, Heinz Feldmann, Hideki Ebihara.   

Abstract

Marburg virus belongs to the genus Marburgvirus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates. Similar to the more widely known Ebola hemorrhagic fever, MHF is characterized by systemic viral replication, immunosuppression and abnormal inflammatory responses. These pathological features of the disease contribute to a number of systemic dysfunctions including hemorrhages, edema, coagulation abnormalities and, ultimately, multiorgan failure and shock, often resulting in death. A detailed understanding of the pathological processes that lead to this devastating disease remains elusive, a fact that contributes to the lack of licensed vaccines or effective therapeutics. This article will review the clinical aspects of MHF and discuss the pathogenesis and possible options for diagnosis, treatment and prevention.

Entities:  

Year:  2011        PMID: 22046196      PMCID: PMC3201746          DOI: 10.2217/fvl.11.79

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  90 in total

1.  The use of interferon for emergency prophylaxis of marburg hemorrhagic fever in monkeys.

Authors:  A A Kolokol'tsov; I A Davidovich; M A Strel'tsova; A E Nesterov; O A Agafonova; A P Agafonov
Journal:  Bull Exp Biol Med       Date:  2001-07       Impact factor: 0.804

2.  Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method.

Authors:  Yohei Kurosaki; Allen Grolla; Aiko Fukuma; Heinz Feldmann; Jiro Yasuda
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

Review 3.  The Marburg virus outbreak of 1967 and subsequent episodes.

Authors:  W G Slenczka
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

4.  Marburg agent disease: in monkeys.

Authors:  D I Simpson
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

5.  [A case of a laboratory infection with Marburg fever].

Authors:  V V Nikiforov; Iu I Turovskiĭ; P P Kalinin; L A Akinfeeva; L R Katkova; V S Barmin; E I Riabchikova; N I Popkova; A M Shestopalov; V P Nazarov
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1994 May-Jun

6.  Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants.

Authors:  M Hevey; D Negley; J Geisbert; P Jahrling; A Schmaljohn
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

7.  Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Authors:  Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

8.  Imported case of Marburg hemorrhagic fever - Colorado, 2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-12-18       Impact factor: 17.586

9.  Rapid detection protocol for filoviruses.

Authors:  Manfred Weidmann; Elke Mühlberger; Frank T Hufert
Journal:  J Clin Virol       Date:  2004-05       Impact factor: 3.168

10.  Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.

Authors:  Thomas W Geisbert; Kathleen M Daddario-Dicaprio; Joan B Geisbert; Douglas S Reed; Friederike Feldmann; Allen Grolla; Ute Ströher; Elizabeth A Fritz; Lisa E Hensley; Steven M Jones; Heinz Feldmann
Journal:  Vaccine       Date:  2008-10-18       Impact factor: 3.641

View more
  32 in total

1.  Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies.

Authors:  Alison E Heald; Patrick L Iversen; Jay B Saoud; Peter Sazani; Jay S Charleston; Tim Axtelle; Michael Wong; William B Smith; Apinya Vutikullird; Edward Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.

Authors:  Veronica V Nicholas; Rebecca Rosenke; Friederike Feldmann; Dan Long; Tina Thomas; Dana P Scott; Heinz Feldmann; Andrea Marzi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 3.  Achieving cross-reactivity with pan-ebolavirus antibodies.

Authors:  Liam B King; Jacob C Milligan; Brandyn R West; Sharon L Schendel; Erica Ollmann Saphire
Journal:  Curr Opin Virol       Date:  2019-03-15       Impact factor: 7.090

4.  Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Authors:  Colm Atkins; Jinxin Miao; Birte Kalveram; Terry Juelich; Jennifer K Smith; David Perez; Lihong Zhang; Jonna L B Westover; Arnaud J Van Wettere; Brian B Gowen; Zhongde Wang; Alexander N Freiberg
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 5.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.

Authors:  Wenjun Zhu; Zirui Zhang; Shihua He; Gary Wong; Logan Banadyga; Xiangguo Qiu
Journal:  Antiviral Res       Date:  2018-02-03       Impact factor: 5.970

Review 7.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

8.  New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model.

Authors:  Timothy K Cooper; Jennifer Sword; Joshua C Johnson; Amanda Bonilla; Randy Hart; David X Liu; John G Bernbaum; Kurt Cooper; Peter B Jahrling; Lisa E Hensley
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 9.  Vaccines for viral hemorrhagic fevers--progress and shortcomings.

Authors:  Darryl Falzarano; Heinz Feldmann
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

10.  Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

Authors:  Emmie de Wit; Kyle Rosenke; Robert J Fischer; Andrea Marzi; Joseph Prescott; Trenton Bushmaker; Neeltje van Doremalen; Shannon L Emery; Darryl Falzarano; Friederike Feldmann; Allison Groseth; Thomas Hoenen; Bonventure Juma; Kristin L McNally; Melvin Ochieng; Victor Omballa; Clayton O Onyango; Collins Owuor; Thomas Rowe; David Safronetz; Joshua Self; Brandi N Williamson; Galina Zemtsova; Allen Grolla; Gary Kobinger; Mark Rayfield; Ute Ströher; James E Strong; Sonja M Best; Hideki Ebihara; Kathryn C Zoon; Stuart T Nichol; Tolbert G Nyenswah; Fatorma K Bolay; Moses Massaquoi; Heinz Feldmann; Barry Fields
Journal:  J Infect Dis       Date:  2016-06-21       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.